REZZAYO
NDC 70842-240, rezafungin, injection, powder, lyophilized, for solution, from Melinta Therapeutics, LLC.
- Product NDC
- 70842-240
- Status
- Listed
- Labeler
- Melinta Therapeutics, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217417
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70842-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REZAFUNGIN200 mg/1
Pharmacologic classes
Echinocandin Antifungal [EPC]; Lipopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70842-240-01 | 70842024001 | 1 VIAL in 1 CARTON (70842-240-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/90073508-6dca-4d27-aa5a-ed837737c35bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70842-240
Use it
Look up 70842-240 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70842-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70842-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.